Browse the evidence

Mitochondrial/ER localization of 1,2-DAGs is positively related to insulin sensitivity, whereas mitochondrial ceramide accumulation is inversely related.

Mitochondrial health is crucial for insulin sensitivity. The presence of certain lipids (1,2-DAGs) in the mitochondria is associated with better insulin sensitivity, possibly by supporting mitochondrial dynamics. This suggests that supporting mitochondrial function through exercise may be more important than simply lowering total muscle fat.

Bariatric surgery (Roux-en-Y Gastric Bypass or Sleeve Gastrectomy) achieves the highest rates of Type 2 Diabetes (T2D) remission compared to dietary interventions, with short-term remission rates up to 80% and long-term durability superior to non-surgical methods.

Bariatric surgery (specifically Roux-en-Y or Sleeve Gastrectomy) is currently the most effective intervention for reversing Type 2 Diabetes, offering the highest remission rates (up to 80% short-term) and better long-term durability than dietary interventions alone. It works through complex hormonal and metabolic changes, not just weight loss. However, it carries surgical risks and requires lifelong commitment to dietary and medical follow-up.

Low-Calorie Diets (LCD), specifically very low-calorie diets (VLCD) of 600-853 kcal/day, can induce Type 2 Diabetes remission in the short term (up to 2 years), particularly in patients with shorter diabetes duration (<4-6 years).

Very Low-Calorie Diets (600-853 kcal/day) using meal replacements for 3-5 months can reverse Type 2 Diabetes in nearly half of patients, especially if diagnosed recently. This approach works by reducing liver and pancreas fat. However, maintaining remission long-term is challenging, and success is highest in those with shorter diabetes duration.

Hyperinsulinemia is a causal driver of obesity and lipid accumulation, rather than merely a compensatory response to insulin resistance or caloric surplus.

If you struggle with obesity, high insulin levels may be driving your fat storage, not just a result of it. Strategies that lower insulin (like low-carb diets, time-restricted feeding, or exercise) may be more effective for weight loss than calorie restriction alone, as they address the hormonal driver of lipid accumulation.

Low-carbohydrate diets (LCDs) and low-fat diets (LFDs) result in equivalent weight loss when caloric restriction is matched, though LCDs may be preferred for patients with insulin resistance.

Whether you choose low-carb or low-fat, the key is sticking to a calorie deficit. If you have insulin resistance or type 2 diabetes, a low-carb approach might offer additional metabolic benefits, but for general weight loss, both are equally effective if calories are matched.

Physical inactivity is highly prevalent across all stages of chronic kidney disease (CKD), with prevalence worsening as disease progresses, reaching a nadir in patients requiring dialysis.

If you have kidney disease, know that being inactive is very common, especially as your condition advances or if you are on dialysis. This is not your fault; factors like fatigue, treatment schedules, and fear of harm are real barriers. Start small: even short, moderate walks (30-60 mins, 3x/week) are safe and beneficial. Focus on building confidence (self-efficacy) and readiness to change rather than intense workouts immediately.

Higher cardiorespiratory fitness (VO2 peak) and higher hemoglobin (Hb) levels are associated with reduced odds of being physically inactive in CKD patients, particularly in those on dialysis and transplant recipients.

If you have advanced kidney disease, your energy levels (influenced by hemoglobin) and fitness (VO2 peak) are key to staying active. Work with your nephrologist to manage anemia, as this can improve your capacity for exercise. Improving your cardiorespiratory fitness, even slightly, can significantly increase your likelihood of being active, especially if you are on dialysis or have had a transplant.

Exercise interventions significantly improve muscle strength and physical performance in older adults with sarcopenia, but do not significantly increase muscle mass.

If you have sarcopenia, regular exercise (30-80 minutes, 1-5 times a week for at least 6 weeks) will likely make you stronger and improve your walking speed and balance. However, do not expect exercise alone to significantly increase your muscle size; combining exercise with nutrition (like protein) may be necessary for mass gain.

Type 2 diabetes mellitus is associated with a significantly higher prevalence of sarcopenia (defined by low lean mass and muscle weakness) compared to healthy controls, independent of diabetes duration or glycemic control.

If you have Type 2 Diabetes, you are at significantly higher risk for muscle loss than someone without diabetes, even if your blood sugar is well-controlled. This loss is not just 'aging'; it is a specific complication of the disease. You should ask your doctor to check your muscle strength (e.g., handgrip) and lean mass, as early detection allows for rehabilitation to restore physical capacity.

Higher Body Mass Index (BMI) and the presence of osteoporosis increase the likelihood of sarcopenia in Type 2 Diabetes patients, while hypertension and a healthy diet decrease it.

For diabetics, maintaining a healthy diet (specifically high fruit and vegetable intake) is a powerful protective factor against muscle loss, potentially more so than just managing blood sugar. Conversely, having osteoporosis significantly increases your risk of sarcopenia. Managing blood pressure and maintaining a healthy weight are also critical components of preserving muscle mass.

Anti-obesity drugs (phentermine/topiramate, liraglutide, naltrexone/bupropion, lorcaserin, orlistat) produce clinically significant weight loss (2.9% to 6.8% placebo-subtracted) over 12+ months, but require careful risk-benefit assessment due to adverse effects and high cost.

If lifestyle changes aren't enough, anti-obesity drugs can help you lose 3-7% more weight than placebo over a year. However, these drugs have side effects and costs. You must discuss your specific health history with a doctor to choose the right option, as some drugs have been withdrawn due to safety concerns like cancer risk.

Liraglutide (3.0 mg) produces significant weight loss (-5.4% placebo-subtracted) and improves cardiovascular risk factors, but has a high discontinuation rate due to gastrointestinal side effects.

Liraglutide is a daily injection that helps lose about 5% more weight than placebo and improves heart health markers. However, it often causes nausea and vomiting, leading many patients to stop taking it.

For very short bouts of physical activity (less than 1 minute), a minimum proportion of vigorous intensity (at least 12-15%) is required to significantly reduce the risk of Major Adverse Cardiovascular Events (MACE), though all-cause mortality benefits may appear at lower vigorous thresholds.

If you can only manage very short bursts of activity (under a minute), make sure they include some vigorous effort, like running up stairs quickly or walking very fast. This high-intensity component is crucial for protecting your heart when the duration is minimal.

Obesity-related sub-acute chronic inflammation acts as a pathologic mediator for both type 2 diabetes and atherosclerotic cardiovascular disease, with inflammatory markers like CRP predicting risk independently of weight.

If you have obesity or type 2 diabetes, your body's chronic low-grade inflammation is likely driving your risk for heart disease and worsening insulin resistance. While weight loss reduces this inflammation, specific anti-inflammatory strategies (like certain diabetes or cardiovascular drugs) may offer additional protection. Discuss with your doctor whether your current regimen addresses inflammatory risk, not just blood sugar or weight.

Acute vigorous submaximal exercise (67% VO2max for 60 minutes) significantly increases circulating GDF15 levels in humans, with levels continuing to rise during the recovery period.

Performing vigorous exercise (around 67% of your max capacity) for an hour triggers a significant rise in GDF15, a hormone linked to appetite suppression and energy balance. This rise continues for at least two hours after you stop exercising. While this doesn't mean your muscles are releasing the hormone directly, the systemic effect is real and substantial.

The metabolic effects of dietary fiber on host phenotypes (adiposity, liver triglycerides, serum glucose) are modulated by the composition of the gut microbiome, meaning identical fiber interventions produce divergent health outcomes depending on the individual's microbial community.

Don't assume all fiber supplements or high-fiber diets will yield the same results for you as they do for others. Your gut bacteria determine how fiber affects your metabolism. If you aren't seeing metabolic improvements from a specific fiber type, it may be due to your unique microbiome composition rather than the fiber itself being ineffective for everyone.

Chronic insufficient sleep (<6 hours/night) and circadian misalignment in military personnel cause significant mental and physical derangements, including increased risk for cardiovascular disease, PTSD, and cognitive failure.

Prioritize 7-9 hours of sleep as a non-negotiable part of your daily routine, especially before high-stress operations. Treat sleep with the same discipline as physical training. If you are struggling with sleep, address it early to prevent long-term health issues like cardiovascular disease or PTSD.

Night shift work and rapid time-zone changes disrupt circadian rhythms, leading to increased morbidity, mortality, and cognitive impairment.

If you work night shifts, use bright light exposure during your shift and wear blue-light-blocking glasses on your commute home. Prioritize a dark, quiet sleeping environment during the day. Be aware that long-term night work increases health risks, so monitor your health closely.

Insulin resistance (IR) and hyperinsulinemia are key etiological components of PCOS that drive excessive ovarian androgen production, leading to reproductive dysfunction, independent of but amplified by obesity.

Understanding that insulin resistance drives PCOS symptoms is crucial. Treating insulin resistance through diet and lifestyle can help reduce androgen levels and restore ovulation, even without significant weight loss.

Higher dietary fiber intake is associated with a 25% reduction in all-cause mortality in adults with established cardiovascular disease.

If you have heart disease, eating more fiber-rich foods like whole grains, fruits, and vegetables can help you live longer. Studies show that people with heart disease who eat more fiber have a 25% lower risk of dying from any cause compared to those who eat less fiber.

Higher total daily sedentary time is independently associated with increased cancer mortality risk in middle-aged and older adults, regardless of moderate-to-vigorous physical activity (MVPA) levels.

If you are over 45, your total daily sitting time matters for your long-term survival risk, independent of how much you exercise. Use an accelerometer or pedometer to track total sedentary minutes. Aim to reduce total sitting time, not just to 'get your workout in,' but to lower your baseline risk profile.

Regular aerobic exercise increases HDL cholesterol levels and enhances Reverse Cholesterol Transport (RCT) efficiency by upregulating key receptors (ABCA1, ABCG1, SR-B1) and enzymes (LCAT, CETP).

Engage in regular aerobic exercise, such as walking or cycling. You do not need extreme intensity; even moderate activities like walking 10,000 steps three times a week can improve your HDL cholesterol and overall lipid profile. Consistency is key, and combining aerobic with resistance training may offer additional benefits.

Dietary strategies that replace carbohydrates with saturated fats (e.g., cheese, meat, butter) or include monounsaturated/polyunsaturated fats (e.g., olive oil) can increase HDL cholesterol levels.

Consider reducing your carbohydrate intake and replacing it with healthy fats, such as those found in olive oil, nuts, or even moderate amounts of saturated fats from cheese and meat. This dietary shift can help increase your HDL cholesterol levels.

Caffeine improves endurance performance only in individuals with the CYP1A2 AA genotype (fast metabolizers), while impairing performance in those with the CC genotype.

If you use caffeine for performance, know your CYP1A2 genotype. If you are a 'fast metabolizer' (AA), standard doses (2-4 mg/kg) likely boost your endurance. If you are a 'slow metabolizer' (CC), caffeine may actually hurt your performance and increase health risks like hypertension. If you are intermediate (AC), you likely see no benefit. Genetic testing can prevent wasted effort or performance loss.